$ACB Aurora is down 10% AH after the ER. Net cannabis revenue up 61% sequentially to $94.6 millionCanadian consumer cannabis revenue up 52% to $44.9 millionMedical cannabis revenue up 10% to $29.7 millionWholesale revenues of $20.1 millionCash cost to produce per gram sold declined 20% sequentially to $1.14 per gram in Q4 2019.Production volume increased 86% sequentially to 29,034 kgs.Gross margin on cannabis net revenue increased by 3% to 58% sequentially.Aurora's medical patient base expanded 10% to 84,729 sequentially. As at the date of this release, Aurora has approximately 89,700 active registered patients, a further increase of 6%.Adjusted EBITDA loss of $11.7 million represents an improvement of 68% compared to $36.6 million in Q3 2019. Subsequent Events Closed an amended and upsized $360 million secured credit facility which includes an accordion feature that enables Aurora to upsize the facility by approximately $40 million,Sold its remaining 28,833,334 shares of The Green Organic Dutchman Holdings Ltd ("TGOD"), at a price of $3.00 per share for aggregate gross proceeds of $86.5 million, representing an approximate 50% internal rate of return for the Company.Full Year Fiscal 2019 HighlightsNet revenue of $247.9 million, up 349% compared to the prior year.Gross margin on cannabis net revenue of 55% in fiscal 2019 versus 65% in fiscal 2018.Kilograms produced and kilograms sold of 57,442 kgs and 36,628 kgs, up 920% and 629% respectively compared to fiscal 2018. notes via danish m.ACB stock is $5.64 AH: $ACB, Aurora Cannabis Inc. / H1